top
Search terms
Results 1 - 3 of 3 - ordered by :
Ejhf

Despite the availability of a number of different classes of therapeutic agents with proven efficacy in heart failure, the clinical course of heart failure patients is characterized by a reduction in ...

European Journal of Heart Failure, Cowie, Martin R., Filippatos, Gerasimos S., Alonso Garcia, Maria de los Angeles, Anker, Stefan D., Baczynska, Anna, Bloomfield, Daniel M., Borentain, Maria, Bruins ...

Date : 01/06/2017 Item size : 89798 bytes
Ejhf

Nitric oxide, endothelial endothelin type B receptor, vascular endothelial growth factor, and cAMP act as mediators for the vasodilatory as well as anti-fibrotic and anti-inflammatory effects of ...

European Journal of Heart Failure, Teerlink, John R., Voors, Adriaan A., Ponikowski, Piotr, Pang, Peter S., Greenberg, Barry H., Filippatos, Gerasimos, Felker, G. Michael, Davison, Beth A., Cotter, ...

Date : 01/06/2017 Item size : 210651 bytes
Ehjournal

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF) Methods and ...

European Heart Journal, Pang, Peter S., Butler, Javed, Collins, Sean P., Cotter, Gad, Davison, Beth A., Ezekowitz, Justin A., Filippatos, Gerasimos, Levy, Phillip D., Metra, Marco, Ponikowski, Piotr, ...

Date : 07/08/2017 Item size : 322415 bytes